Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0093 | 0.1516 | 0.1496 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.0178 | 1 |
Brugia malayi | RNA binding protein | 0.0198 | 0.3607 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0122 | 0.2098 | 0.5789 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0025 | 0.0178 | 1 |
Giardia lamblia | DINP protein human, muc B family | 0.0019 | 0.0055 | 0.5 |
Echinococcus granulosus | dna polymerase kappa | 0.0019 | 0.0055 | 0.0032 |
Loa Loa (eye worm) | TAR-binding protein | 0.0198 | 0.3607 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0198 | 0.3607 | 0.3592 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0093 | 0.1516 | 0.4165 |
Schistosoma mansoni | tar DNA-binding protein | 0.0198 | 0.3607 | 0.3592 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.0178 | 0.5 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0025 | 0.0178 | 0.5 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0025 | 0.0178 | 0.5 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0198 | 0.3607 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0055 | 0.0773 | 0.2144 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0093 | 0.1516 | 0.4202 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0019 | 0.0055 | 0.5 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0019 | 0.0055 | 0.0152 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0019 | 0.0055 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0773 | 0.2094 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0055 | 0.0089 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0019 | 0.0055 | 0.5 |
Brugia malayi | MH2 domain containing protein | 0.0122 | 0.2098 | 0.5816 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0093 | 0.1516 | 0.1496 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0038 | 0.0426 | 0.1181 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0093 | 0.1516 | 0.1496 |
Schistosoma mansoni | DNA polymerase eta | 0.0019 | 0.0055 | 0.0032 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0093 | 0.1516 | 0.1496 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0093 | 0.1516 | 0.1496 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0198 | 0.3607 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0055 | 0.0773 | 0.2144 |
Echinococcus multilocularis | tar DNA binding protein | 0.0198 | 0.3607 | 0.3592 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0122 | 0.2098 | 0.5789 |
Schistosoma mansoni | tar DNA-binding protein | 0.0198 | 0.3607 | 0.3592 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0019 | 0.0055 | 0.0032 |
Schistosoma mansoni | tar DNA-binding protein | 0.0198 | 0.3607 | 0.3592 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0019 | 0.0055 | 0.0032 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0019 | 0.0055 | 0.0152 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0019 | 0.0055 | 0.0032 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0019 | 0.0055 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.0178 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.0178 | 0.0433 |
Loa Loa (eye worm) | RNA binding protein | 0.0198 | 0.3607 | 1 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0019 | 0.0055 | 0.0032 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0093 | 0.1516 | 0.1496 |
Brugia malayi | hypothetical protein | 0.0025 | 0.0178 | 0.0494 |
Echinococcus granulosus | dna polymerase eta | 0.0019 | 0.0055 | 0.0032 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.0426 | 0.1125 |
Leishmania major | hypothetical protein, conserved | 0.0025 | 0.0178 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0093 | 0.1516 | 0.1496 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0019 | 0.0055 | 0.5 |
Echinococcus granulosus | tar DNA binding protein | 0.0198 | 0.3607 | 0.3592 |
Schistosoma mansoni | hypothetical protein | 0.0038 | 0.0426 | 0.0404 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0019 | 0.0055 | 0.0089 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0017 | 0.0023 | 0.0064 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0019 | 0.0055 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0019 | 0.0055 | 0.5 |
Echinococcus multilocularis | dna polymerase eta | 0.0019 | 0.0055 | 0.0032 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0017 | 0.0023 | 0.0064 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0055 | 0.0773 | 0.2094 |
Brugia malayi | TAR-binding protein | 0.0198 | 0.3607 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0198 | 0.3607 | 0.3592 |
Echinococcus multilocularis | dna polymerase kappa | 0.0019 | 0.0055 | 0.0032 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.0178 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 29.0929 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.